Diagnosis, treatment and transmission of rifampicin-resistant TB in the Netherlands, 2010-2019

New tools for diagnosis and treatment of rifampicin-resistant (RR-) and multidrug-resistant (MDR-) TB have become available in the last decade, including better tests confirming transmission. To analyse transmission risks of MDR/RR-TB in the Netherlands. Analysis of national data of patients with MD...

Full description

Bibliographic Details

Published in:	The international journal of tuberculosis and lung disease Vol. 27; no. 6; p. 471
Main Authors:	de Vries, G, Akkerman, O, Boeree, M, van Hest, R, Kamst, M, de Lange, W, Magis-Escurra, C, Meijer, W, van Soolingen, D
Format:	Journal Article
Language:	English
Published:	France 01.06.2023
Subjects:	Antitubercular Agents - pharmacology Female Humans Mycobacterium tuberculosis - genetics Netherlands - epidemiology Rifampin - pharmacology Rifampin - therapeutic use Tuberculosis, Multidrug-Resistant - diagnosis Tuberculosis, Multidrug-Resistant - drug therapy Tuberculosis, Multidrug-Resistant - epidemiology Tuberculosis, Pulmonary - diagnosis Netherlands
ISSN:	1815-7920, 1815-7920
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!